Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease

  1. Albiñana, V.
  2. Gallardo-Vara, E.
  3. de Rojas-P, I.
  4. Recio-Poveda, L.
  5. Aguado, T.
  6. Canto-Cano, A.
  7. Aguirre, D.T.
  8. Serra, M.M.
  9. González-Peramato, P.
  10. Martínez-Piñeiro, L.
  11. Cuesta, A.M.
  12. Botella, L.M.
Aldizkaria:
Journal of Clinical Medicine

ISSN: 2077-0383

Argitalpen urtea: 2020

Alea: 9

Zenbakia: 9

Orrialdeak: 1-30

Mota: Artikulua

DOI: 10.3390/JCM9092740 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus